OTC COVID-19 Tests Have Abbott Seeing Continuing Demand For At-Home Diagnostics
Executive Summary
“We see this is a as a significant opportunity, and quite frankly, a trend that's been happening overseas and is kind of now happening here in the US,” says Abbott Labs CEO Robert Ford.
You may also be interested in...
US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?
Consumer health product firms’ vistas include challenges of supply chain disruptions lingering from pandemic’s impact as well as potential for marketplace restrictions as additional varieties of the novel coronavirus spread. Clouds also include shifts in consumer spending, increases in costs caused by inflation and foreign exchange headwinds as the value of the US dollar strengthens against other currencies.
Expected Spread Of US OTC Diagnostics Could Change Consumers’ Health Care Behaviors
Diagnostics platform provider Ash Wellness expects at-home test providers can help improve consumers’ long-term health care outcomes with follow-up and ongoing communications for users of their products, influencing them to change behaviors.
Expected Spread Of US OTC Diagnostics Could Change Consumers’ Health Care Behaviors
Diagnostics platform provider Ash Wellness expects at-home test providers can help improve consumers’ long-term health care outcomes with follow-up and ongoing communications for users of their products, influencing them to change behaviors.